Janux Therapeutics Statistics

Total Valuation

JANX has a market cap or net worth of $1.40 billion. The enterprise value is $429.85 million.

Market Cap	1.40B
Enterprise Value	429.85M

Important Dates

The last earnings date was Thursday, May 8, 2025, after market close.

Earnings Date	May 8, 2025
Ex-Dividend Date	n/a

Share Statistics

JANX has 59.18 million shares outstanding. The number of shares has increased by 24.21% in one year.

Current Share Class	59.18M
Shares Outstanding	59.18M
Shares Change (YoY)	+24.21%
Shares Change (QoQ)	+8.73%
Owned by Insiders (%)	6.63%
Owned by Institutions (%)	85.75%
Float	37.08M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	147.83
Forward PS	n/a
PB Ratio	1.42
P/TBV Ratio	1.40
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	46.04
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 58.47, with a Debt / Equity ratio of 0.02.

Current Ratio	58.47
Quick Ratio	58.26
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -9.32% and return on invested capital (ROIC) is -8.28%.

Return on Equity (ROE)	-9.32%
Return on Assets (ROA)	-8.16%
Return on Invested Capital (ROIC)	-8.28%
Return on Capital Employed (ROCE)	-10.99%
Revenue Per Employee	$115,259
Profits Per Employee	-$959,778
Employee Count	81
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -47.76% in the last 52 weeks. The beta is 3.24, so JANX's price volatility has been higher than the market average.

Beta (5Y)	3.24
52-Week Price Change	-47.76%
50-Day Moving Average	28.00
200-Day Moving Average	41.83
Relative Strength Index (RSI)	38.06
Average Volume (20 Days)	1,241,139

Short Selling Information

The latest short interest is 9.65 million, so 16.31% of the outstanding shares have been sold short.

Short Interest	9.65M
Short Previous Month	9.34M
Short % of Shares Out	16.31%
Short % of Float	26.03%
Short Ratio (days to cover)	10.07

Income Statement

In the last 12 months, JANX had revenue of $9.34 million and -$77.74 million in losses. Loss per share was -$1.37.

Revenue	9.34M
Gross Profit	-70.04M
Operating Income	-113.58M
Pretax Income	-44.05M
Net Income	-77.74M
EBITDA	-111.54M
EBIT	-113.58M
Loss Per Share	-$1.37

Full Income Statement

Balance Sheet

The company has $1.01 billion in cash and $22.61 million in debt, giving a net cash position of $991.53 million or $16.76 per share.

Cash & Cash Equivalents	1.01B
Total Debt	22.61M
Net Cash	991.53M
Net Cash Per Share	$16.76
Equity (Book Value)	1.01B
Book Value Per Share	17.11
Working Capital	1.01B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$46.00 million and capital expenditures -$533,000, giving a free cash flow of -$46.53 million.

Operating Cash Flow	-46.00M
Capital Expenditures	-533,000
Free Cash Flow	-46.53M
FCF Per Share	-$0.79

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-1,216.61%
Pretax Margin	-832.71%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

JANX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-24.21%
Shareholder Yield	-24.21%
Earnings Yield	-5.47%
FCF Yield	-3.27%

Analyst Forecast

The average price target for JANX is $94.29, which is 297.68% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$94.29
Price Target Difference	297.68%
Analyst Consensus	Strong Buy
Analyst Count	7
Revenue Growth Forecast (5Y)	105.85%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

JANX has an Altman Z-Score of 38.66 and a Piotroski F-Score of 1.

Altman Z-Score	38.66
Piotroski F-Score	1